IAG Wealth Partners’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-100
Closed -$2.67K 442
2023
Q3
$2.67K Hold
100
﹤0.01% 391
2023
Q2
$3.7K Hold
100
﹤0.01% 389
2023
Q1
$3.12K Hold
100
﹤0.01% 404
2022
Q4
$2.98K Hold
100
﹤0.01% 385
2022
Q3
$4K Hold
100
﹤0.01% 356
2022
Q2
$5K Hold
100
﹤0.01% 330
2022
Q1
$6K Hold
100
﹤0.01% 334
2021
Q4
$10K Hold
100
﹤0.01% 299
2021
Q3
$9K Hold
100
﹤0.01% 281
2021
Q2
$10K Sell
100
-50
-33% -$3.99K ﹤0.01% 264
2021
Q1
$15K Hold
150
0.01% 210
2020
Q4
$8K Hold
150
﹤0.01% 262
2020
Q3
$7K Buy
+150
New +$4.7K ﹤0.01% 258

Other funds holding FLGT

IAG Wealth Partners's FLGT Position: Q4 2023 in Review

IAG Wealth Partners sold out of Fulgent Genetics (FLGT) in Q4 2023, closing a stake of 100 shares — an estimated $2.67K sold.

IAG Wealth Partners first reported a position in FLGT in Q3 2020 and held it in 13 quarters. The position peaked at $15K in Q1 2021. 196 funds tracked by Wall St. Rank hold FLGT as of Q4 2023.

  • IAG Wealth Partners reported no remaining Fulgent Genetics position as of Q4 2023 after selling out during the quarter.
  • IAG Wealth Partners sold 100 Fulgent Genetics shares in Q4 2023, an estimated $2.67K.
  • IAG Wealth Partners first reported a position in Fulgent Genetics in Q3 2020 and held it in 13 quarters.
  • IAG Wealth Partners's Fulgent Genetics position peaked at $15K in Q1 2021.
  • 196 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2023.

Based on IAG Wealth Partners's 13F filing for Q4 2023, filed 2 Feb 2024.